Recent studies have shown that, due to the presence of enhanced TIM-3 on monocytes in chronic hepatitis B patients, this molecule plays a key role in the pathogenesis of chronic hepatitis B (65). This evidence concerns the gene HAVCR2 and chronic hepatitis B virus infection.